Author | Sample | Cancer Type and Treatment |
Yoga Intervention | Outcome Measures Reported in Current Review |
---|---|---|---|---|
Bower et al., 2011 [18] | T1 = 12, T2 = 11 Age range: 46–65 Mean age = 54 |
Breast (Stages 0–2) All had completed radiation therapy or radiation therapy + chemotherapy |
90-minute classes twice weekly for 12 weeks Type: Iyengar Yoga |
Quality of Life -SF-36 Psychosocial -BDI-II Symptom -PSQI, FSI |
| ||||
Danhauer et al., 2008 [19] | T1 = 51, T2 = 43 Age range: 34–82 Mean age = 59 |
Ovarian (n = 37) Breast (n = 14) Radiation therapy (n = 5) Chemotherapy (n = 29) |
75-minute weekly classes for 10 weeks Type: Integral Yoga |
Quality of Life -FACT-G, SF-12 Psychosocial -CES-D, FACIT-Sp, PANAS, STAI Symptom -FACT-F |
| ||||
Duncan et al., 2008 [20] | T1 = 24, T2 = 22 Age range: NR Mean age = 49 |
Breast (42%) Gynecologic (16.6%) Lymphoma (12.5%) Currently on or <6 months post treatment |
90 minute weekly classes for 10 weeks Type: Iyengar Yoga |
Quality of Life -FACT-G Psychosocial -FACIT-Sp |
| ||||
Galantino et al., 2011 [21] | T1 = 10, T2 = 10 Age range: 50–71 Median age = 58 |
Breast (Stages I–III) >4 weeks post-chemotherapy and/or post-radiation, all women taking aromatase inhibitors |
90-minute classes twice weekly for 8 weeks, home practice encouraged Type: Iyengar-inspired |
Quality of Life -FACT-B |
| ||||
Speed-Andrews et al., 2010 [22] | T1 = 17, T2 = 17 Age range: not reported Mean age = 54 |
Breast (Stages I–III) Surgery (n = 23) Radiation therapy (n = 19) Chemotherapy (n = 18) Hormone therapy (n = 10) |
Two different sessions; 90 minute classes twice weekly for 6 weeks and 90 minute classes 22 times over 12 weeks Type: Iyengar Yoga |
Quality of Life -FACT-B, SF-36 Psychosocial -CES-D, STAI |
| ||||
Ülger and Yağlı, 2010 [23] | T1 = 20, T2 = 20 Age range: 30–50 Mean age = 41 |
Breast >6 months post-chemotherapy |
60 minute weekly classes for 8 weeks Type: Not specified (“Classical Yoga”) |
Quality of Life -NHP Psychosocial -STAI |
Abbreviations: T1: baseline; T2: follow-up; SF-36 and SF-12: Medical Outcomes Study Short-Form Health Survey; EORTC QLQ C30: European Organization for Research and Treatment of Cancer-Quality of Life C30; FACT-B: Functional Assessment of Cancer Therapy—Breast; FACT-G: Functional Assessment of Cancer Therapy—General; NHP: Nottingham Health Profile; BDI: Beck Depression Inventory; CES-D 20: Center for Epidemiologic Studies Depression Scale—20 Item; STAI: State/Trait Anxiety Inventory; POMS: Profile of Mood States; PANAS: Positive and Negative Affect Schedule; FACIT-Sp: Functional Assessment of Chronic Illness Therapy-Spiritual Well-Being; HADS: Hospital Anxiety and Depression Scale; BFI: Brief Fatigue Inventory; PSQI: Pittsburgh Sleep Quality Index; FSI: Fatigue Symptom Inventory; FACT-F: Functional Assessment of Cancer Therapy-Fatigue. NR: Not Reported.